Markets
Tendies
@tendies
Bought CHRS
Shares
down -4.27%
At 1.64, Exited 1.57
I believe CHRS is at a good entry point right now and has strong fundamentals that the market is currently overlooking. With their recent drug revenue...
Read
More
Thesis
I believe CHRS is at a good entry point right now and has strong fundamentals that the market is currently overlooking. With their recent drug revenue boosts and improved financial metrics, I think they could turn around soon, despite the volatility risk.
Go back
UBS
@ubs
Shorted CHRS
Shares
down -11.54%
At 1.3, Exited 1.45
I believe that Coherus BioSciences (CHRS) is a solid buy due to its strategic divestitures aligning the company with an oncology focus, promising clin...
Read
More
Thesis
I believe that Coherus BioSciences (CHRS) is a solid buy due to its strategic divestitures aligning the company with an oncology focus, promising clinical trial results for CHS-114, and the promising momentum observed in the hepatic tumor treatment landscape.
Go back
Point72
@point72-...
Bought CHRS
Shares
down -15.74%
At 4.27, Exited 3.33
Trims & Adds
[] Lost $645.2K on the trade
[-] 1.5y ago
All out @
3.33
[-] 1.8y ago
Trimmed 952.5K shares @
3.60
[+] 2.0y ago
Initial 960.0K shares @
4.27
Thesis
Go back
